Carcinogenesis, Vol. 20, No. 11, 2137-2142,
November 1999
© 1999 Oxford University Press
Molecular Epidemiology And Cancer Prevention |
Inhibitory effects of deferoxamine on UVB-induced AP-1 transactivation
Department of Radiation Oncology, The University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
Production of reactive oxygen species (ROS) by iron can contribute directly to DNA and protein damage and may contribute to cell signaling and proliferation. We have examined the effects of the iron(III) chelator deferroxamine (DFO) and iron (FeCl3) on UVB (290–320 nm)-induced activator protein 1 (AP-1) signaling. The ability of DFO to inhibit UVB-induced AP-1 transactivation was tested in a human keratinocyte cell line stably transfected with a luciferase reporter driven by a single AP-1 element. DFO treatment 24 h prior to UVB irradiation reduced UVB-induced AP-1 transactivation by ~80%, with the effect of DFO diminishing as pre-treatment time was shortened. Treatment with FeCl3 a minimum of 6 h prior to UVB potentiated the UVB induction of AP-1 transactivation by 2–3-fold. DFO was able to ablate both the UVB induction of AP-1 transactivation as well as the potentiation by FeCl3. The antioxidants Trolox and N-acetyl cysteine were both able to inhibit UVB-induced AP-1 transactivation and Trolox was able to inhibit the potentiation of UVB-induced AP-1 by FeCl3. These results indicate that UVB-induced AP-1 activation may be in part due to oxidant effects of UVB and intercellular iron.
Abbreviations: AP-1, activator protein 1; DFO, deferoxamine; DMEM, Dulbecco's modified Eagle's medium; EGTA, ethylene glycol tetraacetic acid; HCL14, HaCaT cells containing AP-1 regulated luciferase reporter gene; NAC, N-acetyl cysteine; RLU, relative light units; ROS, reactive oxygen species; Trolox-Me, Trolox methyl ether.
1 To whom correspondence should be addressed Email: bowden{at}azcc.arizona.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. E. Dickinson, T. F. Melton, E. R. Olson, J. Zhang, K. Saboda, and G. T. Bowden Inhibition of Activator Protein-1 by Sulforaphane Involves Interaction with Cysteine in the cFos DNA-Binding Domain: Implications for Chemoprevention of UVB-Induced Skin Cancer Cancer Res., September 1, 2009; 69(17): 7103 - 7110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Unger, J. A. Wiesinger, L. Hao, and J. L. Beard Dopamine D2 Receptor Expression Is Altered by Changes in Cellular Iron Levels in PC12 Cells and Rat Brain Tissue J. Nutr., December 1, 2008; 138(12): 2487 - 2494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Lagan, D. D. Melley, T. W. Evans, and G. J. Quinlan Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L161 - L174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Rezazadeh, A R Nayebi, A Garjani, A Sheikhulislami, and H Babaei Evidence that iron overload plus croton oil induce skin tumours in mice Human and Experimental Toxicology, August 1, 2005; 24(8): 409 - 413. [Abstract] [PDF]
|
|
|
|
 |
|
 O. Kakhlon, Y. Gruenbaum, and Z. I. Cabantchik Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells Blood, May 1, 2001; 97(9): 2863 - 2871. [Abstract] [Full Text] [PDF]
|
|